Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Hercules Capital Provides US$15M From Existing Facility for Mesoblast to Accelerate Product Commercialization Programs

firstwordpharmaJanuary 15, 2019

Tag: Mesoblast , Hercules Capital , Commercialization Programs

PharmaSources Customer Service